FDA Guidance on Overall Survival Assessment in ...

By Staff Writer

August 20, 2025

Overall survival assessment serves as the gold standard for determining the true impact of oncology treatments, directly answering patient and provider questions such as: “How will this therapy affect my length of life?” According to the latest FD...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...
Novartis Gains Approval for Groundbreaking Malaria Treatment for Infants
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical ...
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer
Market Leadership in Sight as Eli Lilly’s Oral GLP-1 Medication Orforglipron ...
Personalized Cancer Vaccine in High-Risk Kidney Cancer Patients
MPA Meningioma Risk: Key Insights and Implications
Diabetes Drugs Safe from Thyroid Cancer Risk, Study Finds
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer
Heplisav-B: A Superior Hepatitis B Vaccine for Individuals with HIV